Advances on research of structure and function of puromycin sensitive aminopeptidase
10.16438/j.0513-4870.2022-1052
- VernacularTitle:嘌呤霉素敏感的氨肽酶结构与功能研究进展
- Author:
Chen-yang JIAO
;
Yan LI
;
Qiang XU
;
Wen-jie GUO
- Publication Type:Research Article
- Keywords:
M1 aminopeptidase;
puromycin-sensitive aminopeptidase;
structure and function;
isease;
inhibitor
- From:
Acta Pharmaceutica Sinica
2023;57(8):2130-2138
- CountryChina
- Language:Chinese
-
Abstract:
Puromycin-sensitive aminopeptidase (PSAP) belongs to the M1 family of aminopeptidases, characterized by the N-terminal substrate binding sequence GAMEN, the enzyme activity center HEXXH(X)18E motif, and the C-terminal ERAP-1-like superfamily structural domain. Encoded by the gene NPEPPS located at 17q21.32, PSAP consists of 919 amino acids and is widely distributed throughout the human body, with the highest expression in the brain, followed by the heart and skeletal muscle. It is also found in the liver, renal tubular epithelium, small intestine, large intestine epithelium, and gastric epithelial cells. PSAP primarily relies on its aminopeptidase hydrolytic activity to remove toxic protein aggregates such as Tau, poly Q, and Cu, Zn-superoxide dismutase 1, making it an important factor in the development of diseases such as Alzheimer's disease, Huntington's chorea, and tumors. Existing PSAP inhibitors include bestatin, amastatin, leuhistin, actinonin, and purinomycin, some of which are already available or in clinical trials. This review provides an overview of the structural and biological functions of M1 family aminopeptidases, with a focus on PSAP, to facilitate further research and targeted drug development.
